Suppr超能文献

泰国北部骨肉瘤的年龄标准化发病率和生存率

AgeStandardized Incidence Rates and Survival of Osteosarcoma in Northern Thailand.

作者信息

Pruksakorn Dumnoensun, Phanphaisarn Areerak, Pongnikorn Donsuk, Daoprasert Karnchana, Teeyakasem Pimpisa, Chaiyawat Parunya, Katruang Narisara, Settakorn Jongkolnee

机构信息

Orthopedic Laboratory and Research Netting Center (OLARN Center), Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Thailand Email :

出版信息

Asian Pac J Cancer Prev. 2016;17(7):3455-8.

Abstract

Osteosarcoma is a common primary malignant bone tumor in children and adolescents. Recent worldwide average incidences of osteosarcoma in people aged 0 to 24 years were 4.3 and 3.4 per million, respectively, with a ratio of 1.4:1. However, data on the incidence of osteosarcoma in Thailand are limited. This study analyzed the incidence of osteosarcoma in the upper northern region of Thailand, with a population of 5.85 million people (8.9% of the total Thai population), using data for the years 1998 to 2012, obtained from the Chiang Mai Cancer Registry (CMCR) at Chiang Mai University Hospital and the Lampang Cancer Registry (LCR) at the Lampang Cancer Hospital, a total of 144 cases. The overall annual incidence of osteosarcoma was 1.67 per million with a male:female ratio of 1.36:1. Incidences by age group (male and female) at 0 to 24, 25 to 59 and over 60 years were 3.5 (3.9 and 3.0), 0.8 (0.9 and 0.6), and 0.7 (0.8 and 0.5), respectively. The peak incidence occurred at 15 to 19 years for males and at 10 to 14 years for females. The median survival time was 18 months with a 5year survival rate of 43%. Neither the age group nor the 5year interval period of treatment was significantly correlated with survival during the 15year period studied.

摘要

骨肉瘤是儿童和青少年常见的原发性恶性骨肿瘤。最近全球0至24岁人群中骨肉瘤的平均发病率分别为每百万4.3例和3.4例,男女比例为1.4:1。然而,泰国骨肉瘤发病率的数据有限。本研究利用1998年至2012年的数据,分析了泰国北部地区的骨肉瘤发病率,该地区人口为585万(占泰国总人口的8.9%),数据来自清迈大学医院的清迈癌症登记处(CMCR)和南邦癌症医院的南邦癌症登记处(LCR),共144例。骨肉瘤的总体年发病率为每百万1.67例,男女比例为1.36:1。0至24岁、25至59岁和60岁以上年龄组(男性和女性)的发病率分别为3.5(3.9和3.0)、0.8(0.9和0.6)和0.7(0.8和0.5)。男性的发病高峰年龄在15至19岁,女性在10至14岁。中位生存时间为18个月,5年生存率为43%。在所研究的15年期间,年龄组和5年治疗间隔期均与生存无显著相关性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验